Furthermore, we have investigated the effects of (Pro 3 )GIP, exendin(939)amide and a combination of both peptides on the insulin and glycaemic responses to feeding in obese hyperglycaemic ( ob / ob ) mice, a commonly used animal model of Type 2 diabetes with marked hyperinsulinaemia due to enhanced activity of the enteroinsular axis [27]
In addition, long-term use of GLP-1RAs may also have potential safety risks, such as pancreatitis (Shetty et al., 2022) and thyroid diseases ( 6 Discussion T2DM is a chronic disease characterized by hyperglycemia, which eventually leads to microvascular damage and macrovascular events, as well as complications related to peripheral vascular diseases
Our providers closely monitor your response to the medication, adjusting your treatment plan as needed to help you achieve your health and weight loss goals safely and effectively
Read more in Scientific American: #GLP1 #WeightLossDrugs #ObesityResearch #HeartHealth #MedicalNews #MedEd To view or add a comment, sign in More Relevant Posts GLP1 weightloss injections can lead to clinically significant weight loss, but longterm results depend on more than the medication alone
MARD is the difference of the CGM reading from the reference or standard-of-care measurement
